ESMO 2016 Congress
For more details about the Industry Satellite Symposia, please visit our ESMO 2016 Industry Satellite Symposia programme
- Challenge Your Expert (CYE) session
- ESMO Colloquium
- Educational session
- Industry Satellite Symposium
- Joint Symposium
- Keynote lecture
- Multidisciplinary patient cases
- Patient Advocacy Track
- Poster Discussion session
- Poster Display
- Presidential Symposium
- Proffered Paper session
- Special Session
- Special Symposium
- Young Oncologist Brunch
- Young Oncologist Forum
- Young Oncologist Mentorship session
- Young Oncologist Special session
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
Copenhagen
Vienna
Stockholm
- 09:00(1h 30m)Advances in targeted therapy in gynaecological cancers
- 16:30(1h 30m)HER2+ advanced breast cancer: A few more questions and many more answers
- 13:00(1h)Industry Satellite Symposium
- 14:45(1h 30m)Liquid biopsies
- 11:00(1h 30m)Transforming academia-industry partnerships to expedite clinical development of innovative anti-cancer agents
Madrid
- 11:00(1h)Current options for recurrent platinum sensitive ovarian cancer
- 18:30(1h 30m)ESMO Colloquium - Immune checkpoint inhibition and chemotherapy in NSCLC and breast cancer: A Flamenco or a Tango?
- 16:30(1h)Gastrointestinal tumours, colorectal
- 13:00(1h 30m)Industry Satellite Symposium
- 15:00(1h)Liver dominant disease
- 09:30(1h)Treatment approaches in elderly patients
Oslo
- 09:00(1h 30m)Biomarker strategies to improve the treatment of castration-resistant prostate cancer
- 11:00(1h 30m)Head and neck cancers
- 13:00(1h 30m)Industry Satellite Symposium
- 18:30(1h 30m)Industry Satellite Symposium
- 14:45(1h 30m)Management of advanced radioactive-iodine (RAI) refractory differentiated thyroid cancer (DTC)
- 16:30(1h 30m)Public health and health economics
Rome
- 09:15(1h 30m)Clinical challenges and patient needs based on defined supportive and palliative interventions delivered by competent multidisciplinary professionals
- 16:30(1h 30m)Endocrine and neuroendocrine tumours
- 13:00(1h 30m)Industry Satellite Symposium
- 18:30(1h 30m)Industry Satellite Symposium
- 11:00(1h)Melanoma and other skin tumours
- 15:00(1h)Oligometastatic disease in prostate cancer patients
- 08:00(1h)Synchronous metastatic colorectal cancer: Addressing difficult situations
Athens
- 16:30(1h)Challenges in the management of HPV - associated OPC
- 14:45(1h 30m)Drugs you will be using in 2020
- 13:00(1h 30m)Industry Satellite Symposium
- 18:30(1h 30m)Industry Satellite Symposium
- 08:00(1h)Lights and shadows in targeting KRAS driven lung cancer
- 09:15(1h 30m)Rare lymphomas: Recent developments in diagnostic and treatment
- 11:00(1h 30m)Using biomarkers to monitor the dynamics of tumour responses to therapy
Helsinki
- 13:00(1h 30m)Industry Satellite Symposium
- 18:30(1h 30m)Industry Satellite Symposium
- 14:45(1h 30m)Joint Symposium ESMO-MASCC: Controversies in supportive care
- 11:00(1h 30m)Streamlining the equitable delivery of anti-cancer drugs: Sharing common grounds for a pan-European vision of value
- 09:30(1h)Targeting the genes is not enough: The patients and tumour behaviour also matter
Brussels
- 08:00(1h)Are guidelines necessary for everyday treatment in metastatic breast cancer?
- 13:00(1h 30m)Industry Satellite Symposium
- 18:30(1h 30m)Industry Satellite Symposium
- 09:15(1h 30m)Joint Symposium ESMO-DSKO: Perspectives in the registration and use of Big Data and individual molecular profiles
- 11:00(1h)Sarcoma
- 14:45(1h 30m)Straightforward options for earlier detection and treatment of challenging cancer types
Berlin
Bern
Lisbon
- 14:15(1h 30m)ESMO Fellowships and Awards
- 16:00(1h 30m)Professional development and communication skills
- 08:00(1h)The development of novel anticancer drugs: How to raise the bar in oncology
- 09:30(1h)What are genomics adding to patient management?
- 11:00(45m)What makes a good review article? The Editors perspective
Central Hall